latest news releases from the newsroom
QLogic Ships Virtual HBA Technology for SUSE Linux Enterprise Server from Novell
SALT LAKE CITY, March 20, 2008 (PRIME NEWSWIRE) -- Novell BrainShare 2008 -- QLogic Corp. (Nasdaq:QLGC), a leader in networking for storage and high performance computing (HPC), today announced that it is the first HBA vendor to ship production ready N_Port ID Virtualization (NPIV) solution for a shipping Linux distribution. Enterprise Linux customers can now get NPIV-capable Fibre Channel HBAs for SUSE Linux Enterprise Server 10 Service Pack 1 (SP1), the latest Linux platform from Novell that features significant enhancements in virtualization, high performance computing, security, interoperability and system management. QLogic(r) market-leading 2400 series HBAs provide hardware-assist features that enable dynamic provisioning and flexible usage of HBA resources, helping IT managers to extend SAN best practices into virtualized data centers.
Icagen and Pfizer Form Collaboration With Birkbeck, University of London to Elucidate Channel Structure
RESEARCH TRIANGLE PARK, N.C., March 20, 2008 (PRIME NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that, together with Pfizer, it has entered into a collaboration with the laboratory of Professor B. A. Wallace at Birkbeck, University of London, to study the structural biology of sodium channels. This three party relationship has been established to support a previously established collaboration between Icagen and Pfizer for the discovery of compounds which modulate specific sodium ion channels as potential new treatments for pain and related disorders.
Radyne Reaffirms Strategic Alternative Review
PHOENIX, March 20, 2008 (PRIME NEWSWIRE) -- Radyne Corporation (Nasdaq:RADN) announced today that its exploration of strategic alternatives is continuing. As previously announced, the Company retained Needham & Company as its financial advisor to assist it in exploring strategic alternatives, including a possible sale of the Company. Although an evaluation process continues, including discussions with various interested parties, the Company has not set any time frame for conclusion of the process. There cannot be any assurance that a transaction, whether a sale, recapitalization or other event, will take place. The Company does not anticipate making another announcement in regard to this matter until a definitive transaction has been agreed to, or it has concluded its evaluation efforts.